A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Anti-Calcium Channel (?4 Subunit) (Voltage Gated Ca2+ Channel) antibody produced in rabbit | ~1 mg/mL, buffered aqueous solution, fractionated antiserum. Group: Fluorescence/luminescence spectroscopy. |  |
| Anti-Calcium Channel (?4 Subunit) (Voltage Gated Ca2+ Channel) antibody produced in rabbit | ~1 mg/mL, fractionated antiserum, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calcium Channel (?5 subunit) antibody produced in rabbit | ~1 mg/mL, fractionated antiserum, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calcium Channel (Cardiac ?1C Subunit) (L-type of Voltage-gated Ca2+ Channel) antibody produced in rabbit | affinity isolated antibody, lyophilized powder. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calcium Channel CaV1.2 (human) antibody produced in rabbit | affinity isolated antibody, lyophilized powder. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calcium Channel CaV3.1 (?1G) antibody produced in rabbit | affinity isolated antibody, lyophilized powder. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calcium Channel CaV3.2 (?1H) antibody produced in rabbit | affinity isolated antibody, lyophilized powder. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calcium Channel CaV3.3 (?1I) antibody produced in rabbit | affinity isolated antibody, lyophilized powder. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calnexin antibody, Mouse monoclonal | clone TO-5, purified from hybridoma cell culture. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calnexin antibody produced in rabbit | IgG fraction of antiserum, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calpain-10 (Domain T, N-Terminal), Large Subunit antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calpain-13 (Domain III, N-Terminal), Large Subunit antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calpain-13 (Domain I, N-Terminal), Large Subunit antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calpain-2, Large Subunit antibody produced in rabbit | 1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calpain-5 (Domain III), Large Subunit antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calpain-5 (Domain II), Large Subunit antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calpain-5 (Domain I, N-Terminal), Large Subunit antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calpain-5 (Domain IV, C-Terminal), Large Subunit antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calpain-7 (Domain I, C-Terminal), Large Subunit antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calpain-7 (Domain III, C-Terminal), Large Subunit antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calpain-7 (Domain I, N-Terminal), Large Subunit antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calpain-7 (Domain N, C-Terminal), Large Subunit antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calpain-94 (Catalytic Domain), Large Subunit antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calpain-94 (Domain II), Large Subunit antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calpain-9 (Domain II, Catalytic Domain), Large Subunit antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calpain-9 (Domain I), Large Subunit antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calpain-9 (Domain IV, C-Terminal), Large Subunit antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calpain-9 (Domain IV) (EF-1), Large Subunit antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calpain LP-82/LP-85 (Lens-Specific Calpain) (Domain III), Large Subunit antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calpain LP-85 (Lens-Specific Calpain) (Domain IV), Large Subunit antibody produced in rabbit | ~1 mg/mL, affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-CALR antibody produced in rabbit | affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calreticulin antibody produced in rabbit | IgG fraction of antiserum, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calretinin antibody produced in rabbit | affinity isolated antibody, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calsequestrin-1 antibody produced in rabbit | ~1.6 mg/mL, affinity isolated antibody, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calsequestrin-1 (N-terminal) antibody produced in rabbit | affinity isolated antibody. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Calsequestrin-2 antibody produced in rabbit | ~1.0 mg/mL, affinity isolated antibody, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-CAMK2B antibody produced in rabbit | affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-CaM Kinase II? (CaMKII?) antibody produced in rabbit | IgG fraction of antiserum, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-CaM Kinase IV (CaMKIV) (AY-18) antibody produced in rabbit | IgG fraction of antiserum, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-CAMKK2 antibody produced in rabbit | affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-CAMKV antibody produced in rabbit | affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Cancer Active Compound Library | A unique collection of 2114 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); - Effective tool for molecular mechanism of tumorigenesis, and anti-tumor drug screening; - Covers various major targets including PI3K, HDAC, mTOR, CDK, Aurora Kinase, JAK, etc. - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality. Uses: Scientific use. Product Category: L2160. Categories: Anti-Cancer Active Compounds Libraries. |  |
| Anti-Cancer Approved Drug Library | A unique collection of 1726 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS); - These FDA, EMA, or NMPA approved anti-cancer drugs have annotated bioactivity, safety, and bioavailability; - Effective tool for cancer research and drug repurposing screening; - Covers various major targets including PI3K, HDAC, mTOR, CDK, Aurora Kinase, JAK, etc. , in lung cancer, breast cancer, leukemia, lymphoma, etc. - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality. Uses: Scientific use. Product Category: L2110. Categories: Anti-Cancer Approved Drug Libraries. | |
| Anti-Cancer Clinical Compound Library | A unique collection of 1990 anti-cancer compounds for high throughput screening (HTS) and high content screening (HCS); - Bioactivity confirmed by pre-clinical research and all of them are currently in clinical trial phases, representing the cutting-edge treatments for cancers; - Effective tool for cancer research and drug repurposing screening; - Covers various major targets including PI3K, HDAC, mTOR, CDK, Aurora Kinase, JAK, etc. , in lung cancer, breast cancer, leukemia, lymphoma, etc. - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality. Uses: Scientific use. Product Category: L2120. Categories: Anti-Cancer Clinical Compounds Libraries. | |
| Anti-Cancer Compound Library | A unique collection of 5885 compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS); - Bioactivity and safety profiled in (confirmed by) pre-clinical and clinical settings (research and trials); - Effective tool for molecular mechanism of tumorigenesis, and anti-tumor drug screening; - Covers various major targets including PI3K, HDAC, mTOR, CDK, Aurora Kinase, JAK, etc. - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality. Uses: Scientific use. Product Category: L2100. Categories: Anti-Cancer Compounds Libraries. | |
| Anti-Cancer Drug Library | A unique collection of 2478 anticancer drugs for high throughput screening (HTS) and high content screening (HCS); - Bioactivity and safety profiled in (confirmed by) pre-clinical and clinical settings (research and trials), an effective tool for molecular mechanism of tumorigenesis, and anti-tumor drug repositioning drug discovery; - Covers various major targets including PI3K, HDAC, mTOR, CDK, Aurora Kinase, JAK, etc; involved in 15 different cancer research areas, such as lung cancer, breast cancer, leukemia, lymphoma, etc. - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality. Uses: Scientific use. Product Category: L2150. Categories: Anti-Cancer Drug Libraries. | |
| Anti-Cancer Library Plus | Quantity: well-chosen 1468 anti-tumor compounds with unique structures; - High antitumor activity: 99% of compounds with IC50 below 3 μM; - Covers 42 tumor related targets with each compound having clear target; - Detailed information: each compound has information about activity testing method, providing reference for your experimental design; - HNMR/LCMS validated to ensure high purity and quality; - A supplemental tool for anticancer drug development and target identification. Uses: Scientific use. Product Category: L2180. Categories: Anti-Cancer Libraries Plus. | |
| Anti-Cancer Metabolism Compound Library | A unique collection of 1280 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS); - Bioactivity and safety confirmed by pre-clinical research and clinical trials; - Covers 16 major targets related to cancer cellular metabolism (glucose, proteins, lipids and nucleic acids) including ACL, CA, FASN, GLUT, GLS, HMG-CoA, MAGL, MCTs, PDH, PDK, PKM, etc. ; Effect tool for research in cancer metabolism and anti-cancer drug screening. - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality. Uses: Scientific use. Product Category: L2130. Categories: Anti-Cancer Metabolism Compounds Libraries. | |
| Anticancerous peptide 1 | Anticancerous peptide 1 is an antimicrobial peptide produced by Cycas revoluta (Sago palm). It has antibacterial and anticancer activity. Synonyms: Cr-ACP1; Ala-Trp-Lys-Leu-Phe-Asp-Asp-Gly-Val; Cycas revoluta-anticancerous peptide 1. Grades: ≥97%. Molecular formula: C50H71N11O14. Mole weight: 1050.18. |  |
| Anticancer peptide A2 | Anticancer peptide A2 is an antimicrobial peptide produced by Synthetic construct. It has antibacterial activity against Gram-negative bacterium: Escherichia coli (MIC>250 μM). Synonyms: Gly-Leu-Phe-Asp-Lys-Leu-Lys-Ser-Leu-Val-Ser-Asp-Phe; Antibacterial peptide A2. Grades: >97%. Molecular formula: C69H109N15O20. Mole weight: 1468.71. | |
| Anticancer peptide A4 | Anticancer peptide A4 is an antimicrobial peptide produced by Synthetic construct. It has antibacterial activity against Gram-negative bacterium: Escherichia coli (MIC=100 μM). Synonyms: Gly-Leu-Phe-Asp-Ile-Val-Lys-Lys-Leu-Val-Ser-Asp-Phe; Antibacterial peptide A4. Grades: ≥96%. Molecular formula: C71H113N15O19. Mole weight: 1480.77. | |
| Anti-Cannabinoid receptor 1 antibody produced in goat | affinity isolated antibody, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Cannabinoid receptor 2 antibody produced in goat | affinity isolated antibody, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Cannabinoid Receptor 2 antibody produced in rabbit | affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-CAPN10 antibody produced in rabbit | affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-CAPN1 antibody produced in rabbit | affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-CAPN2 antibody produced in rabbit | affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-CAPNS1 antibody produced in rabbit | affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anticapsin | Anticapsin is an antibiotic produced by Streptomyces griseoplanus. It can also be produced by acid hydrolysis of Bacilysin. 3 μg/mL Anticapsin can inhibit the formation of hyaluronic acid capsule by Streptococcus pyogenes. Except for Salmonella gallisepticum (MIC 6.25 μg/mL), low concentration has no obvious antibacterial activity against other microorganisms. Synonyms: 7-Oxabicyclo[4.1.0]heptane-2-propanoic acid, (1R-(1.alpha.,2.alpha.(S*),6.alpha.))-. CAS No. 28978-07-6. Molecular formula: C9H13NO4. Mole weight: 199.20. | |
| Anti-CARD12 antibody produced in rabbit | affinity isolated antibody. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-CARD9 antibody produced in rabbit | affinity isolated antibody, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-CARD9 antibody produced in rabbit | ~0.5 mg/mL, affinity isolated antibody, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Cardiovascular Disease Compound Library | A unique collection of 1428 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS); - Bioactivity and safety confirmed by pre-clinical research and clinical trials and most of them are approved by FDA, EMA, or NMPA; - Covers various major targets including membrane transporter, ion channel, etc. ; Effect tool for research in cardiovascular disease. - Detailed compound information with structure, target, activity, IC50 value, and biological activity description; - Structurally diverse, medicinally active, and cell permeable; - NMR and HPLC validated to ensure high purity and quality. Uses: Scientific use. Product Category: L5400. Categories: Anti-Cardiovascular Disease Compounds Libraries. | |
| Anti-CASEIN Kinase 1? antibody produced in goat | affinity isolated antibody, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-Casein Kinase 2? antibody, Mouse monoclonal | clone 6D5, purified from hybridoma cell culture. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-CASK/LIN2 (KA-17) antibody produced in rabbit | affinity isolated antibody, buffered aqueous solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-CASP10 antibody produced in rabbit | affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-CASP3 antibody produced in rabbit | IgG fraction of antiserum. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-CASP3 antibody produced in rabbit | affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
| Anti-CASP4 antibody produced in rabbit | affinity isolated antibody, buffered aqueous glycerol solution. Group: Fluorescence/luminescence spectroscopy. | |
Our database is helping our users find suppliers everyday.
